Shortening of treatment duration in patients with chronic hepatitis C genotype 2 and 3 - impact of ribavirin dose - a randomized multicentre trial
2011 · BMC Research Notes · 1 citations
https://doi.org/10.1186/1756-0500-4-220
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
3.8K
Citations
31
h-index
50
i10-index
Martin Bischof is an academic researcher from Krankenhaus der Elisabethinen. The author has contributed to research in topics: Liver Disease Diagnosis and Treatment & Diabetes Management and Research & Hepatitis C virus research. The author has an h-index of 31, co-authored 84 publications.
https://doi.org/10.1186/1756-0500-4-220
https://doi.org/10.1007/s00508-016-0966-0
Click to start Chat